Can Oral THC Data From Monkeys Predict When an Edible Peaks in Humans?
A vervet-monkey study observed oral THC concentration peaks around four hours, but that is not a universal timetable for human edibles. The experiment helps characterize an animal model while also showing why repeated exposure and the particular analyte matter.
What was measured?
Huppé-Gourgues and colleagues administered THC orally to vervet monkeys under acute and short repeated-exposure conditions. Blood samples were analyzed by high-performance liquid chromatography–tandem mass spectrometry for THC and its metabolites.
The principal comparisons included the first dosing day and day eight. This was pharmacokinetic research: the outcomes were measured chemical concentrations, rather than a human driving test or an assessment of whether participants could safely perform a task.
Not every analyte followed the same pattern
THC concentrations rose after dosing, with observed peaks around four hours on both study days. The active metabolite 11-hydroxy-THC showed a similar time course. Baseline THC before dosing was higher on day eight than on day one.
THC-COOH did not show a statistically significant increase in the reported comparisons. A claim that all metabolites accumulated together would erase this null finding. Parent THC, the active hydroxylated metabolite, and the carboxy metabolite should be named separately.
An observed peak is bounded by sampling
A peak in collected samples identifies the highest measured point in that sampling schedule. It does not demonstrate that every animal’s biological maximum occurred at exactly that time. Formulation, feeding conditions, dose, and collection timing also define the experiment.
Higher predose THC after repeated administration shows why a later concentration need not represent only the latest dose. It does not establish a validated method for separating old and new exposure from one human sample.
The appropriate translational conclusion
The findings support designing and interpreting subsequent vervet-monkey experiments. They do not validate a human dose conversion, a four-hour clearance rule, or a formula for reconstructing consumption time.
For a human edible case, use human evidence matched to the product, route, specimen, and question. Even a well-characterized concentration curve requires separate behavioral evidence before it can be used to describe functional impairment.
For related context, see our discussion of how edible and vaporized cannabis differ in timing.
Primary research
Frédéric Huppé-Gourgues; Natalie Spridzans; Simon G. Lamarre; Amy Beierschmitt; Roberta M. Palmour; Jean-François Bouchard; Maurice Ptito. Pharmacokinetics of oral Δ9-tetrahydrocannabinol (THC) administration in vervet monkeys. Journal of Cannabis Research (2026). DOI: 10.1186/s42238-026-00422-y.
